Addictive Disorders

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Effects of acute and chronic ketoconazole administration on hypothalamo–pituitary–adrenal axis activity and brain corticotropin-releasing hormone

Gennady N. Smagin and Nick E. Goeders
Psychoneuroendocrinology.Volume 29, Issue 10 , November 2004, Pages 1223-1228  

 

Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders. Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Bridget F. Grant, Frederick S. Stinson, Deborah A. Dawson, S. Patricia Chou, Mary C. Dufour, Wilson Compton, Roger P. Pickering, Kenneth Kaplan

Arch Gen Psychiatry. 2004;61:807-816.

 
Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study.

Seifert J, Peters E, Jahn K, Metzner C, Ohlmeier M, te Wildt B, Emrich HM, Schneider U.

Addict Biol. 2004 Mar;9(1):43-51.

 

A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. 

Smelson DA, Williams J, Ziedonis D, et al. 

J Subst Abuse Treat 2004;27(1):45-49

 

Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity

Robert J. Carey, Gail DePalma, Ernest Damianopoulos, Anthony Hopkins, Arielle Shanahan, Christian P. Müller and Joseph P. Huston

Brain Research. Volume 1019, Issues 1-2, 3 September 2004, Pages 134-143

 

 

Polysomnographic comparison between patients with primary alcohol dependency during subacute withdrawal and patients with a major depression

H. Gann, D. van Calker, B. Feige, O. Cloot, R. Brück, M. Berger and D. Riemann

European Archives of Psychiatry and Clinical Neuroscience 2004; Volume 254, Number 4: 263 - 271

 

Do small lapses predict relapse to smoking behavior under bupropion treatment?
Wileyto P, Patterson F, Niaura R, Epstein L, Brown R, Audrain-McGovern J, Hawk L, Lerman C, Patterson F.

Nicotine Tob Res. 2004 Apr;6(2):357-66.

 

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
Cinciripini P, Wetter D, Tomlinson G, Tsoh J, De Moor C, Cinciripini L, Minna J.

Nicotine Tob Res. 2004 Apr;6(2):229-39.

 

Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence

Andreas Heinz, David Goldman, Jürgen Gallinat, Gunter Schumann and Imke Puls

Psychopharmacology 2004; Volume 174, Number 4: 561 - 570

 

Changes in food reward following smoking cessation: a pharmacogenetic investigation

Caryn Lerman, Wade Berrettini, Angela Pinto, Freda Patterson, Susan Crystal-Mansour, E. Paul Wileyto, Stephanie L. Restine, Debra G. B. Leonard, Peter G. Shields and Leonard H. Epstein

Psychopharmacology 2004; Volume 174, Number 4: 571 - 577

 

 

Gender Differences in Response to Sertraline Pharmacotherapy in Type A Alcohol Dependence
Helen Pettinati, William Dundon, Craig Lipkin

Am J Addict 2004; 13:236 - 247               

 

Methamphetamine Abstinence Syndrome: Preliminary Findings
Thomas Newton, Ari Kalechstein, Sonia Duran, Nicolette Vansluis, Walter Ling

Am J Addict 2004; 13:248–255

 

Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications

Irmgard Tegeder and Gerd Geisslinger

Pharmacol Rev 56:351-369, 2004

 

Methamphetamine Activates Reward Circuitry in Drug Naïve Human Subjects
Birgit A Völlm, Ivan E de Araujo, Philip J Cowen, Edmund T Rolls, Morten L Kringelbach, Katharine A Smith, Peter Jezzard, Ronald J Heal and Paul M Matthews

Neuropsychopharmacology (2004) 29, 1715-1722

 

A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE.
Kiritze-Topor P, Huas D, Rosenzweig C, Comte S, Paille F, Lehert P

Alcohol Alcohol. 2004 Aug 10 [Epub ahead of print]

 

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

 

Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study

J.örg Daumann, Thomas Fischermann, Karsten Heekeren, Armin Thron and Euphrosyne Gouzoulis-Mayfrank

Biological Psychiatry. Volume 56, Issue 5, 1 September 2004, Pages 349-355

.

Regresar a RESÚMENES AGOSTO 2004